Navigation Links
Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
Date:1/23/2009

"The report today that the FDA has approved the first human clinical trial of an embryonic stem cell-based intervention raises important ethical considerations, but not only, or even primarily, because what is at issue is an embryonic stem cell-based intervention. Although deep-seated disagreements about the ethics of embryo research surround the interest in this study, we need to focus as well on this being the first human trial of its kind. Any "first in human beings" medical experiment requires the highest level of moral scrutiny and oversight. At this point it is critical that every effort be made to protect the welfare and rights of the patients who will be approached to be these human subjects. A good place to start would be by NOT referring to this study as a trial of a stem cell-based therapy, as Geron has described it, but rather as a stem cell-based intervention whose therapeutic benefits in humans has not yet been studied. It is also important to emphasize that this trial offers little prospect of clinical improvement to the very first patients who will participate in the safety phase of the research."


'/>"/>

Contact: Ralph Loglisci
RalphL@jhu.edu
410-625-7872
Johns Hopkins Berman Institute of Bioethics
Source:Eurekalert

Page: 1

Related biology news :

1. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
2. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
3. Director of National Intelligence to Speak at Conference
4. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
5. Director of National Intelligence to Speak at Conference
6. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
7. Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States
8. Solidus Networks, Inc. Seats New Board of Directors
9. Fujitsu Announces PalmSecure(TM) LOGONDIRECTOR
10. Julia Zeitlinger selected for NIH Directors New Innovator Award
11. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... Ca (PRWEB) , ... August 16, 2017 , ... ... by changing into a different cell type. Many treatments for specific cancers, such ... prominent example of targeted treatment is androgen deprivation therapy for advanced prostate cancer. ...
(Date:8/16/2017)... Aug. 16, 2017  This year,s edition of the Inc. 5000 features ... sciences workforce solutions, has made the list for the third year in ... nation,s fastest-growing private companies based on a set of quantitative metrics. In ... the fastest-growing companies in the Bay State . ... Inc. 5000 ...
(Date:8/15/2017)... CA (PRWEB) , ... August 15, 2017 , ... ... pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the launch of ... number of steps needed to gain kinetic binding data for a wide range ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum ... Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. The partnership ... 2018, at The Roosevelt Hotel in New York City. , “With our experience in ...
Breaking Biology Technology: